EPA Reaffirms Safety of Glyphosate

WASHINGTON, D.C. – Yesterday, the U. S. Environmental Protection Agency (EPA) released an interim decision updating current glyphosate regulations. After a thorough review of the best available science, as required under the Federal Insecticide, Fungicide, and Rodenticide Act, EPA concluded there are no concerns for human health when glyphosate is used according to the label and that the product is not a carcinogen.

“We appreciate EPA’s thorough review of a product that is an important and effective tool for farmers, foresters, homeowners, and landscape professionals. Having been on the market for more than 40 years, glyphosate-based herbicides are some of the most extensively studied and reviewed pesticide products. Over the past four decades, regulatory scientists have reviewed hundreds of epidemiological studies, long-term animal studies, and genetic toxicity studies from both pesticide companies and third-party organizations,” said CropLife America CEO and President Chris Novak. “These studies have consistently upheld the safety of glyphosate.”

“This decision confirms previous reviews, released last year by both EPA and Health Canada, which reaffirmed that glyphosate poses no risk to public health and is not likely to be carcinogenic. EPA’s most recent assessment is fully consistent with the science-based conclusions reached by the agency and leading health regulators worldwide,” noted RISE President Megan Provost.